"Dich Hochtaunus-Kliniken haben Standorte in Bad Homburg, Usingen und Königstein. Die Kliniken bieten den Patienten neue und individuelle Therapiemöglichkeiten und eine umfassende Diagnostik nach einheitlichen Standards und internationalen Leitlinien."

During the past decade, Hochtaunus-Kliniken conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hochtaunus-Kliniken" #1 sponsor was "AGO Research GmbH" with 2 trials, followed by "Arcagy Research" with 1 trials sponsored, "CENTOGENE GmbH Rostock" with 1 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored and "Grupo Español de Investigación en Cáncer de Ovario" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hochtaunus-Kliniken" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Hochtaunus-Kliniken" are "Recurrent Ovarian Carcinoma" (3 trials), "Ovarian Cancer" (2 trials), "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials), "Cartilage Disease" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Hochtaunus-Kliniken" in a lesser frequency.

Most popular intervention types in "Hochtaunus-Kliniken" are "Drug" (4 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hochtaunus-Kliniken" are 6 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Hochtaunus-Kliniken". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hochtaunus-Kliniken, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hochtaunus-Kliniken, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".